COLUMBIA UNIVERSITY HEALTH SCIENCES
Human ISG15 and USP18 Deficiencies Underlying Type I Interferonopathies
Human ISG15 and USP18 Deficiencies Underlying Type I Interferonopathies is a funding opportunity from COLUMBIA UNIVERSITY HEALTH SCIENCES, up to 465050, closing May 31, 2027.
May 31, 2027
(304d left)Overview
Project Summary Type I interferons (IFN-Is) have well-documented potent antiviral and inflammatory properties. However, we and others have shown that the inflammatory effects of these cytokines can have detrimental effects on human health. Disorders caused by the prolonged effects of IFN-Is are collectively known as…